Defective cerebellar response to mitogenic Hedgehog signaling in Down's syndrome mice

被引:156
作者
Roper, RJ
Baxter, LL
Saran, NG
Klinedinst, DK
Beachy, PA [1 ]
Reeves, RH
机构
[1] NHGRI, NIH, Bethesda, MD 20892 USA
[2] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA
关键词
aneuploicly; neuronal deficit; sonic hedgehog; trisomy; 21;
D O I
10.1073/pnas.0510750103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Trisomy 21 is the cause of Down's syndrome (DS) which is characterized by a number of phenotypes, including a brain which is small and hypocellular compared to that of euploid individuals. The cerebellum is disproportionately reduced. Ts65Dn mice are trisomic for orthologs of about half of the genes on human chromosome 21 and provide a genetic model for DS. These mice display a number of developmental anomalies analogous to those in DS, including a small cerebellum with a significantly decreased number of both granule and Purkinje cell neurons. Here we trace the origin of the granule cell deficit to precursors in early postnatal development, which show a substantially reduced mitogenic response to Hedgehog protein signaling. Purified cultures of trisomic granule cell precursors show a reduced but dose-dependent response to the Sonic hedgehog protein signal in vitro, demonstrating that this is a cell-autonomous deficit. Systemic treatment of newborn trisomic mice with a small molecule agonist of Hedgehog pathway activity increases mitosis and restores granule cell precursor populations in vivo. These results demonstrate a basis for and a potential therapeutic approach to a fundamental aspect of CNS pathology in DS.
引用
收藏
页码:1452 / 1456
页数:5
相关论文
共 37 条
[1]   Chromosome 21 and Down syndrome: From genomics to pathophysiology [J].
Antonarakis, SE ;
Lyle, R ;
Dermitzakis, ET ;
Reymond, A ;
Deutsch, S .
NATURE REVIEWS GENETICS, 2004, 5 (10) :725-738
[2]   Cerebellar volume in adults with Down syndrome [J].
Aylward, EH ;
Habbak, R ;
Warren, AC ;
Pulsifer, MB ;
Barta, PE ;
Jerram, M ;
Pearlson, GD .
ARCHIVES OF NEUROLOGY, 1997, 54 (02) :209-212
[3]   Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse [J].
Baxter, LL ;
Moran, TH ;
Richtsmeier, JT ;
Troncoso, J ;
Reeves, RH .
HUMAN MOLECULAR GENETICS, 2000, 9 (02) :195-202
[4]   Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome [J].
Belichenko, PV ;
Masliah, E ;
Kleschevnikov, AM ;
Villar, AJ ;
Epstein, CJ ;
Salehi, A ;
Mobley, WC .
JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 480 (03) :281-298
[5]   Small molecule modulation of Smoothened activity [J].
Chen, JK ;
Taipale, J ;
Young, KE ;
Maiti, T ;
Beachy, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) :14071-14076
[6]   Activity-dependent internalization of smoothened mediated by β-arrestin 2 and GRK2 [J].
Chen, W ;
Ren, XR ;
Nelson, CD ;
Barak, LS ;
Chen, JK ;
Beachy, PA ;
de Sauvage, F ;
Lefkowitz, RJ .
SCIENCE, 2004, 306 (5705) :2257-2260
[7]   Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion [J].
Cooper, JD ;
Salehi, A ;
Delcroix, JD ;
Howe, CL ;
Belichenko, PV ;
Chua-Couzens, J ;
Kilbridge, JF ;
Carlson, EJ ;
Epstein, CJ ;
Mobley, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10439-10444
[8]  
CROME L, 1966, J MENT DEFIC RES, V10, P69
[9]  
Dahmane N, 1999, DEVELOPMENT, V126, P3089
[10]  
Davisson M T, 1993, Prog Clin Biol Res, V384, P117